Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Secondary to Interaction Between Methotrexate and Etoricoxib: A Case Report

Rheumatoid arthritis (RA) is an autoimmune disease affecting about 1% of people, with the highest incidence between 40 and 70 years. Methotrexate is an anti-folate analogue that has good efficacy and safety in the treatment of RA. Methotrexate (MTX) and non-steroidal anti inflammatory drugs are of...

Full description

Bibliographic Details
Main Authors: P.R Rachana, HV Anuradha, Reddy Mounika
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2015-07-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/6244/14221_CE[Ra1]_F(AK)_PF1(VSUAK)_PFA(P)_PF2(PAG).pdf
_version_ 1818415042945613824
author P.R Rachana
HV Anuradha
Reddy Mounika
author_facet P.R Rachana
HV Anuradha
Reddy Mounika
author_sort P.R Rachana
collection DOAJ
description Rheumatoid arthritis (RA) is an autoimmune disease affecting about 1% of people, with the highest incidence between 40 and 70 years. Methotrexate is an anti-folate analogue that has good efficacy and safety in the treatment of RA. Methotrexate (MTX) and non-steroidal anti inflammatory drugs are often concomitantly administered in clinical practice for the treatment of RA. In this case report, a 57-yearold female was treated with oral methotrexate 7.5 mg per week for a diagnosed case of RA. Since her pain persisted after completing six weeks of treatment with methotrexate, oral etoricoxib 60 mg once daily was added to the treatment regimen. Six weeks later, the patient complained of oral ulcerations and blisters on all fours limbs and trunk. The patient was re-evaluated and was diagnosed with Stevens-Johnson syndrome-Toxic epidermal necrolysis (SJS-TEN) overlap. This case highlights the possible pharmacokinetic interaction between methotrexate and etoricoxib that has a significant clinical implication.
first_indexed 2024-12-14T11:28:43Z
format Article
id doaj.art-44a8a8304ee9444ba077866d8a5d8f84
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-14T11:28:43Z
publishDate 2015-07-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-44a8a8304ee9444ba077866d8a5d8f842022-12-21T23:03:23ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2015-07-0197FD01FD0310.7860/JCDR/2015/14221.6244Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Secondary to Interaction Between Methotrexate and Etoricoxib: A Case ReportP.R Rachana0HV Anuradha1Reddy Mounika2Post Graduate, Department of Pharmaology, M.S Ramaiah Medical College, Bangalore, India.Associate Professor, Department of Pharmacology, M.S Ramaiah Medical College, Bangalore, India.Post Graduate, Department of Dermatology, M.S Ramaiah Medical College, Bangalore, India.Rheumatoid arthritis (RA) is an autoimmune disease affecting about 1% of people, with the highest incidence between 40 and 70 years. Methotrexate is an anti-folate analogue that has good efficacy and safety in the treatment of RA. Methotrexate (MTX) and non-steroidal anti inflammatory drugs are often concomitantly administered in clinical practice for the treatment of RA. In this case report, a 57-yearold female was treated with oral methotrexate 7.5 mg per week for a diagnosed case of RA. Since her pain persisted after completing six weeks of treatment with methotrexate, oral etoricoxib 60 mg once daily was added to the treatment regimen. Six weeks later, the patient complained of oral ulcerations and blisters on all fours limbs and trunk. The patient was re-evaluated and was diagnosed with Stevens-Johnson syndrome-Toxic epidermal necrolysis (SJS-TEN) overlap. This case highlights the possible pharmacokinetic interaction between methotrexate and etoricoxib that has a significant clinical implication.https://jcdr.net/articles/PDF/6244/14221_CE[Ra1]_F(AK)_PF1(VSUAK)_PFA(P)_PF2(PAG).pdfdrug interactionnon-steroidal anti-inflammatory drugsrheumatoid arthritis
spellingShingle P.R Rachana
HV Anuradha
Reddy Mounika
Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Secondary to Interaction Between Methotrexate and Etoricoxib: A Case Report
Journal of Clinical and Diagnostic Research
drug interaction
non-steroidal anti-inflammatory drugs
rheumatoid arthritis
title Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Secondary to Interaction Between Methotrexate and Etoricoxib: A Case Report
title_full Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Secondary to Interaction Between Methotrexate and Etoricoxib: A Case Report
title_fullStr Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Secondary to Interaction Between Methotrexate and Etoricoxib: A Case Report
title_full_unstemmed Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Secondary to Interaction Between Methotrexate and Etoricoxib: A Case Report
title_short Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Secondary to Interaction Between Methotrexate and Etoricoxib: A Case Report
title_sort stevens johnson syndrome toxic epidermal necrolysis overlap secondary to interaction between methotrexate and etoricoxib a case report
topic drug interaction
non-steroidal anti-inflammatory drugs
rheumatoid arthritis
url https://jcdr.net/articles/PDF/6244/14221_CE[Ra1]_F(AK)_PF1(VSUAK)_PFA(P)_PF2(PAG).pdf
work_keys_str_mv AT prrachana stevensjohnsonsyndrometoxicepidermalnecrolysisoverlapsecondarytointeractionbetweenmethotrexateandetoricoxibacasereport
AT hvanuradha stevensjohnsonsyndrometoxicepidermalnecrolysisoverlapsecondarytointeractionbetweenmethotrexateandetoricoxibacasereport
AT reddymounika stevensjohnsonsyndrometoxicepidermalnecrolysisoverlapsecondarytointeractionbetweenmethotrexateandetoricoxibacasereport